John M. Greally

Affiliations: 
Albert Einstein College of Medicine of Yeshiva University, NY, United States 
Google:
"John Greally"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Sosa EA, Rosean S, O'Shea D, et al. (2023) Regulatory Landscape Enrichment Analysis (RLEA) using gaiaAssociation. Biorxiv : the Preprint Server For Biology
Pelletier A, Carrier A, Zhao Y, et al. (2022) Epigenetic and Transcriptomic Programming of HSC Quiescence Signaling in Large for Gestational Age Neonates. International Journal of Molecular Sciences. 23
Kong Y, Rose CM, Cass AA, et al. (2019) Transposable element expression in tumors is associated with immune infiltration and increased antigenicity. Nature Communications. 10: 5228
Bhagat TD, Von Ahrens D, Dawlaty M, et al. (2019) Lactate-mediated epigenetic reprogramming regulates formation of human pancreatic cancer-associated fibroblasts. Elife. 8
Johnston AD, Simões-Pires CA, Thompson TV, et al. (2019) Functional genetic variants can mediate their regulatory effects through alteration of transcription factor binding. Nature Communications. 10: 3472
Bowler TG, Pradhan K, Kong Y, et al. (2019) Misidentification of and other mutations in cancer due to highly homologous genomic regions. Leukemia & Lymphoma. 1-6
Sato H, Wu B, Delahaye F, et al. (2019) Retargeting of macroH2A following mitosis to cytogenetic-scale heterochromatic domains. The Journal of Cell Biology
Kong Y, Rastogi D, Seoighe C, et al. (2019) Insights from deconvolution of cell subtype proportions enhance the interpretation of functional genomic data. Plos One. 14: e0215987
Nakahara F, Borger DK, Wei Q, et al. (2019) Engineering a haematopoietic stem cell niche by revitalizing mesenchymal stromal cells. Nature Cell Biology
Piqué DG, Montagna C, Greally JM, et al. (2019) A novel approach to modelling transcriptional heterogeneity identifies the oncogene candidate CBX2 in invasive breast carcinoma. British Journal of Cancer
See more...